0000000000969616

AUTHOR

E. Vinci

showing 3 related works from this author

P621 Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study

2017

medicine.medical_specialtyPancolitisTumor necrosis factorsbusiness.industryGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisGolimumab03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicinemedicine030211 gastroenterology & hepatologyPredictor variableColitismedicine.symptombusinessmedicine.drugJournal of Crohn's and Colitis
researchProduct

Elevated plasma total homocysteine in centenarians

2004

Homocysteine (Hcy) is a sulfur-containing metabolite of methionine and is an emerging independent risk factor for atherosclerosis. Previous studies have shown that age, gender, renal function and folic acid intake are the main factors influencing total plasma Hcy levels in humans. A unique approach to the science of human longevity is the natural model of centenarians. The objective of this study was to verify whether the previously determined risk factors for atherosclerosis and atherosclerosis-related diseases change with age and, finally, to establish the vitamin nutritional status role. We studied 54 centenarians (14 males and 40 females) aged between 100-107 years (mean age 102.6+/-1.8…

AdultMaleGerontologyVitaminmedicine.medical_specialtyHomocysteineClinical BiochemistryRenal functionBiologychemistry.chemical_compoundFolic AcidInternal medicineBlood plasmamedicineHumansVitamin B12Risk factorAgedAged 80 and overCreatinineMethionineHomocystineBiochemistry (medical)General MedicineMiddle AgedCreatineVitamin B 12EndocrinologychemistryPyridoxal PhosphateRegression AnalysisFemaleClinical Chemistry and Laboratory Medicine (CCLM)
researchProduct

The sicilian network for inflammatory bowel disease (SN-IBD): preliminary data on efficacy of biological therapy.

2017

Introduction: The monitoring of appropriateness, costs, and clinical outcomes of biological therapy in inflammatory bowel disease (IBD) is a relevant need. Aims & Methods: We aimed to evaluate all these issues in Sicily through a webbased network of all prescribing centers. The Sicilian Network for Inflammatory Bowel Disease (SN-IBD) is composed by a super Hub coordinator centre and five Hub plus ten Spoke centres. From January 2013, all IBD patients starting a biological agent (incident cases) or already on treatment (prevalent cases) were entered in a web based software. Herein we report data of incident cases about the efficacy of biological therapy after twelve weeks and one year of…

Settore MED/09 - Medicina InternaSicilian network; inflammatory bowel disease; SN-IBDinflammatory bowel diseaseSN-IBDSicilian network
researchProduct